Cart 0
Compare 0 Wishlist 0
My Account
Menu
₹86

Granicip 1-DT Tablet: Effective Relief for Your Needs

Brand: CIPLA LTD
Product Code: MRM_102429
Reviews: (0)
In Stock
₹86
Buy in one click
Specifications: (see all)
Manufacturer
CIPLA LTD
Origin of Medicine
India
Price for
4 Tablet(s) In A Strip
Salt Composition
Granisetron
Delivery Delivery from India within 15 days. Payment Pay quickly and conveniently Cumulative discounts Collect bonuses and gifts
Granicip 1-DT Tablet

Uses:

  • Prevention or treatment of nausea and vomiting during cancer treatment, including chemotherapy, radiotherapy, or after surgery.

Therapeutic Effects:

  • Works by blocking the action of serotonin (chemical messenger) in the brain, which is responsible for nausea and vomiting during cancer treatment.

Interaction with Other Drugs:

  • Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Granicip 1-DT tablet and cause undesirable side effects.

Safety Advices:

  • Pregnancy: Granicip 1-DT tablet is not safe to be used during pregnancy. Consult with your doctor for advice.
  • Breastfeeding: Granicip 1-DT tablet is used with caution in breastfeeding women as it is unknown if it passes into breast milk. Consult with your physician for advice.
  • Lungs: Inform your physician before starting this treatment if you have lung diseases.
  • Liver: Inform your physician before starting this treatment if you have liver disease.
  • Alcohol: It is unknown whether it is safe to consume alcohol with Granicip 1-DT tablet. Consult your doctor for advice.
  • Driving: Granicip 1-DT tablet usually does not affect your ability to drive and operate heavy machines. Avoid driving or using machinery if you experience side effects.

Side Effects:

  • Serious: allergic reaction (anaphylaxis), skin rashes, abnormal involuntary movements, such as shaking, muscle rigidity and contractions, changes in the heartbeat and ECG readings.
  • Common: headache, constipation, diarrhea, insomnia (difficulty in sleeping), changes in liver function tests.

How to Consume:

  • Swallow the whole Granicip 1-DT tablet with a glass of water. Avoid chewing or breaking the tablet.
  • Your physician will decide the dose and duration depending on the severity of your medical condition.

FAQs:

  • Q1: What is Granicip 1-DT tablet used for?
    • A1: Granicip 1-DT tablet is used to prevent or treat nausea and vomiting during cancer treatment, like radiotherapy, chemotherapy, or after surgery.
  • Q2: Does Granicip 1-DT tablet cause constipation?
    • A2: Yes, Granicip 1-DT tablet can cause constipation, which is one of the side effects of this medication. You can avoid it by eating high-fiber foods in your diet.
  • Q3: Can I drive after taking Granicip 1-DT tablet?
    • A3: Yes, Granicip 1-DT tablet does not affect the ability to drive and operate heavy machines. If you experience any side effects, then avoid driving or operating any machine.
  • Q4: What class of medication is Granicip 1-DT tablet?
    • A4: Granicip 1-DT tablet belongs to the class of medications known as 5-HT3 receptor antagonists or antiemetics.
  • Q5: Who is contraindicated to taking Granicip 1-DT tablet?
    • A5: Patients who have experienced allergic reactions (hypersensitivity), bowel movement problems, heart problems, and pregnant and breastfeeding women should not use Granicip 1-DT tablet.

Fact Box:

  • Molecule name: Granisetron
  • Therapeutic class: 5-HT3 receptor antagonists
  • Pharmacological class: Anti emetics
  • Indications: Prevention or treatment of nausea and vomiting during cancer treatment.

Tags: medical, granicip, tablet, drug, pharmacy, health, cardiology, medicine, treatment

Основные характеристики
Manufacturer
CIPLA LTD
Origin of Medicine
India
Price for
4 Tablet(s) In A Strip
Salt Composition
Granisetron
Reviews
0/ 5
average product rating
0
0
0
0
0
There are no reviews for this product. Be the first to leave your review.